Activities turn research into treatment
December 15th 2010The Association for Research in Vision and Ophthalmology works closely with the National Alliance for Eye and Vision Research to help ensure that adequate funding is available for both basic and translational research for the National Eye Institute.
Supplement to enhance blepharospasm therapy now available by prescription only
December 14th 2010A medical food (Zytaze, OCuSOFT) designed to provide nutritional support to enhance the effectiveness of injections of onabotulinum toxin A (Botox/Botox Cosmetic, Allergan), abobotulinum toxin A (Dysport, Tercica), and rimabotulinum toxin B (Myobloc, Solstice Neurosciences) in the treatment of blepharospasm, hemifacial spasm, and cosmetic procedures now is available in pharmacies as a prescription-only supplement.
System for accelerated corneal crosslinking receives CE mark
December 14th 2010A system for performing accelerated corneal crosslinking (KXL, Avedro) has received the European Union?s (EU?s) CE mark, which certifies that the system has met the EU?s health and safety standards and opens the door to immediate commercialization across the European economic community and in other countries recognizing the CE mark.
Alcon to proceed with corrective action plan for vitreoretinal system
December 14th 2010Alcon Laboratories announced that it received clearance from the FDA to complete its voluntary medical device corrective action plan on its proprietary vitreoretinal system (Constellation Vision System) in the United States.
Accommodative IOLs advance a step further
November 15th 2010Ongoing development of increasingly customized IOLs provides an ophthalmic surgeon with the means to offer refractive cataract surgery patients a lens or a combination of complementary lenses that specifically address their individual needs.
Real-world data: Excellent outcomes achieved with multifocal implantation
November 15th 2010Bilateral implantation of a three-piece aspheric diffractive multifocal IOL with refractive enhancement as needed provides excellent visual outcomes for a broad range of patients seen in real-world clinical practice.